(Q35211257)

English

Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation therapy (ADT).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation therapy (ADT). (English)

1 reference

Europe PubMed Central

7 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Daniel Cho

1

1 reference

Europe PubMed Central

7 August 2017

Christopher J Di Blasio

2

1 reference

Europe PubMed Central

7 August 2017

Audrey C Rhee

3

1 reference

Europe PubMed Central

7 August 2017

Michael W Kattan

4

1 reference

Europe PubMed Central

7 August 2017

publication date

1 July 2003

1 reference

Europe PubMed Central

7 August 2017

Urologic Oncology

1 reference

Europe PubMed Central

7 August 2017

21

1 reference

Europe PubMed Central

7 August 2017

282-291

1 reference

Europe PubMed Central

7 August 2017

4

1 reference

Europe PubMed Central

7 August 2017

A structured debate: immediate versus deferred androgen suppression in prostate cancer-evidence for deferred treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

How much can we rely on the level of prostate-specific antigen as an end point for evaluation of clinical trials? A word of caution!

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Post-therapy serum prostate-specific antigen level and survival in patients with androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of intergroup 0159, cancer and leukemia group B 9480.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Living with treatment decisions: regrets and quality of life among men treated for metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for survival of patients with bidimensionally measurable metastatic hormone-refractory prostatic cancer treated with single-agent chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A retrospective analysis of the relationship between changes in serum PSA, palliative response and survival following systemic treatment in a Canadian randomized trial for symptomatic hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen levels and prognosis in patients with hormone-refractory prostate cancer treated with low-dose dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative clinical trial of adriamycin and 5-fluorouracil in advanced prostatic cancer: Prognostic factors and response

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in patients with advanced prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in metastatic prostate cancer: a nested study within CALGB 9583.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative Nomogram for 12-Year Sarcoma-Specific Death

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of progression: nomograms of clinical utility

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A catalog of prostate cancer nomograms

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Algorithms for prostate-specific antigen recurrence after treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of computer-based clinical decision support systems on clinician performance and patient outcome. A critical appraisal of research

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

International Validation of a Preoperative Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A standardization method to adjust for the effect of patient selection in phase II clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Artificial neural networks improve the accuracy of cancer survival prediction.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A Leisurely Look at the Bootstrap, the Jackknife, and Cross-Validation

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression modelling strategies for improved prognostic prediction

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900057-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1078-1439(03)00057-7

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35211257&oldid=1856241878"